Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:55 AM
Ignite Modification Date: 2025-12-25 @ 4:55 AM
NCT ID: NCT05376618
Eligibility Criteria: 1. case group Inclusion Criteria: 1. Age from 40 to 80 years old; gender is not limited. 2. Stable COPD 3. Sign the informed consent with the willingness of obeying the protocol. - Exclusion Criteria: 1. Subjects with known other chronic respiratory diseases except for COPD (such as asthma, tuberculosis, bronchiectasis, interstitial lung disease, occupational lung diseases, sarcoidosis, lung cancer, et al); 2. Subjects had been accepted lung lobectomy or transplantation; 3. Subjects be ill with severe, or uncontrolled systemic diseases other than COPD (such as psychiatry diseases, chronic liver diseases, heart failure, auto-immunity diseases, chronic renal diseases, et al ); 4. Alcoholism, drug or solvents addition; 5. Acute exacerbation COPD patients (AECOPD) - 2. control group Inclusion criteria 1. Age from 40 to 80 years old; gender is not limited. 2. Sign the informed consent with the willingness of obeying the protocol. - Exclusion criteria <!-- --> 1. Subjects with known other chronic respiratory diseases (such as COPD, asthma, tuberculosis, bronchiectasis, interstitial lung disease, occupational lung diseases, sarcoidosis, lung cancer, et al); 2. Subjects had been accepted lung lobectomy or transplantation; 3. Subjects be ill with severe, or uncontrolled systemic diseases other than COPD (such as psychiatry diseases, chronic liver diseases, heart failure, auto-immunity diseases, chronic renal diseases, et al ); 4. Alcoholism, drug or solvents addition;
Healthy Volunteers: True
Sex: ALL
Minimum Age: 40 Years
Maximum Age: 80 Years
Study: NCT05376618
Study Brief:
Protocol Section: NCT05376618